相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Additional cytogenetic aberrations in chronic myeloid leukemia: a single-center experience in the Middle East
Akbar Safaei et al.
BLOOD RESEARCH (2018)
Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy
Wei Wang et al.
BLOOD (2016)
Isodicentric Philadelphia Chromosome: A Rare Chromosomal Aberration in Imatinib-Resistant Chronic Myelogenous Leukemia Patients - Case Report with Review of the Literature
Krishna C. Ramachandran et al.
CYTOGENETIC AND GENOME RESEARCH (2016)
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML
Alice Fabarius et al.
ANNALS OF HEMATOLOGY (2015)
Chromosomal rearrangement involving 11q23 locus in chronic myelogenous leukemia: a rare phenomenon frequently associated with disease progression and poor prognosis
Wei Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2015)
Novel complex t(V;9;22) rearrangements in three cases with chronic myeloid leukemia and a rare translocation in a case with classical Philadelphia chromosome
Hasmik Mkrtchyan et al.
ONCOLOGY REPORTS (2014)
Sex differences in the incidence of chronic myeloid leukemia
Tomas Radivoyevitch et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2014)
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
Michele Baccarani et al.
BLOOD (2013)
Multiple copies of BCR-ABL fusion gene on two isodicentric Philadelphia chromosomes in an imatinib mesylate-resistant chronic myeloid leukemia patient
Walid Al-Achkar et al.
ONCOLOGY LETTERS (2013)
Cytogenetic profile of 1,863 Ph/BCR-ABL-positive chronic myelogenous leukemia patients from the Chinese population
Qitian Mu et al.
ANNALS OF HEMATOLOGY (2012)
Additional chromosomal abnormalities in Philadelphia-positive clone: adverse prognostic influence on frontline imatinib therapy: a GIMEMA Working Party on CML analysis
Simona Luatti et al.
BLOOD (2012)
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience
Hagop Kantarjian et al.
BLOOD (2012)
Cancer treatment and survivorship statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Down-regulation of Thanatos-associated protein 11 by BCR-ABL promotes CML cell proliferation through c-Myc expression
Satoki Nakamura et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights
Sheryl M. Gough et al.
BLOOD (2011)
Interpretation of cytogenetic and molecular results in patients treated for CML
Carlos E. Vigil et al.
BLOOD REVIEWS (2011)
Chronic myeloid leukemia: mechanisms of blastic transformation
Danilo Perrotti et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Epidemiology of chronic myeloid leukaemia (CML)
Maren Rohrbacher et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2009)
Molecular biology of bcr-abl1-positive chronic myeloid leukemia
Alfonso Quintas-Cardama et al.
BLOOD (2009)
Molecular cytogenetic characterization of variant Philadelphia translocations in chronic myeloid leukemia: genesis and deletion of derivative chromosome 9
Ayda Bennour et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Chronic myeloid leukemia in Asia
Wing Y. Au et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2009)
Ring chromosomes in human neoplasias
E. Gebhart
CYTOGENETIC AND GENOME RESEARCH (2008)
Public Health and Air Pollution in Asia (PAPA): A multicity study of short-term effects of air pollution on mortality
Chit-Ming Wong et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2008)
Multiple sub-microscopic genomic lesions are a universal feature of chronic myeloid leukaemia at diagnosis
J. S. Khorashad et al.
LEUKEMIA (2008)
Genomic profile of chronic myelogenous leukemia: Imbalances associated with disease progression
D. Brazma et al.
GENES CHROMOSOMES & CANCER (2007)
t(3;21)(q26;q22) in myeloid leukemia - An aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy
CC Yin et al.
CANCER (2006)
Management of chronic myeloid leukemia in France: a multicentered cross-sectional study on 538-patients
S Tardieu et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2005)
Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center -: A 4.5-year follow-up
T Lahaye et al.
CANCER (2005)
Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia
R Ren
NATURE REVIEWS CANCER (2005)
Additional clonal abnormalities in Philadelphia-positive ALL and CML demonstrate a different cytogenetic pattern at diagnosis and follow different pathways at progression
U Bacher et al.
CANCER GENETICS AND CYTOGENETICS (2005)
Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate
ME O'Dwyer et al.
BLOOD (2004)
Prognostic significance of cytogenetic clonal evolution in patients with chronic myelogenous leukemia on imatinib mesylate therapy
JE Cortes et al.
BLOOD (2003)
Cytogenetic and molecular genetic evolution of chronic myeloid leukemia
B Johansson et al.
ACTA HAEMATOLOGICA (2002)
Chronic myeloid leukemia and interferon-α:: a study of complete cytogenetic responders
F Bonifazi et al.
BLOOD (2001)
分享论文
